Diplomat Pharmacy Inc  

(Public, NYSE:DPLO)   Watch this stock  
Find more results for DPLO
17.69
+0.08 (0.45%)
Real-time:   3:40PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 17.32 - 17.77
52 week 12.25 - 38.94
Open 17.62
Vol / Avg. 244,050.00/740,298.00
Mkt cap 1.20B
P/E 69.97
Div/yield     -
EPS 0.25
Shares 67.20M
Beta     -
Inst. own 73%
Aug 7, 2017
Q2 2017 Diplomat Pharmacy Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 27, 2017
Diplomat Pharmacy Inc Analyst and Investor Day Add to calendar
Jun 8, 2017
Diplomat Pharmacy Inc Annual Shareholders Meeting - 1:00PM EDT - Add to calendar
Jun 6, 2017
Diplomat Pharmacy Inc Annual Shareholders Meeting (Estimated) - 1:00PM EDT - Add to calendar
May 16, 2017
Diplomat Pharmacy Inc at Bank of America Merrill Lynch Healthcare Conference - Webcast
May 8, 2017
Q1 2017 Diplomat Pharmacy Inc Earnings Call - Webcast
May 8, 2017
Q1 2017 Diplomat Pharmacy Inc Earnings Release
Mar 14, 2017
Diplomat Pharmacy Inc at Barclays Global Healthcare Conference - Webcast
Mar 7, 2017
Diplomat Pharmacy Inc at Raymond James Institutional Investors Conference
Feb 28, 2017
Q4 2016 Diplomat Pharmacy Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 0.39% 0.57%
Operating margin 0.79% 1.07%
EBITD margin - 2.20%
Return on average assets 1.55% 2.38%
Return on average equity 2.84% 5.02%
Employees 1,737 -
CDP Score - -

Address

4100 S Saginaw St
FLINT, MI 48507-2683
United States - Map
+1-888-7204450 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.

Officers and directors

Paul Urick President
Age: 45
Bio & Compensation  - Reuters
Atul Kavthekar Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Gary Rice Executive Vice President - Operations
Age: 59
Bio & Compensation  - Reuters
Philip R. Hagerman Chairman of the Board, Chief Executive Officer, Co-Founder
Age: 64
Bio & Compensation  - Reuters
Benjamin Wolin Lead Independent Director
Age: 42
Bio & Compensation  - Reuters
Gary W. Kadlec Director
Age: 68
Bio & Compensation  - Reuters
Regina M. Benjamin M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 60
Bio & Compensation  - Reuters
Kenneth O. Klepper Independent Director
Age: 63
Bio & Compensation  - Reuters